| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |